KELLIE STURMAN: Open Payments
NPI 1114765625 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 55 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $74 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $286 |
| ABBVIE INC. | 14 | $177 |
| Lilly USA, LLC | 5 | $107 |
| Exact Sciences Corporation | 4 | $85 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| ABIOMED | 2 | $58 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Corcept Therapeutics | 2 | $36 |
Products named: FARXIGA, MOUNJARO, AIRSUPRA, CAPLYTA, The Cologuard Plus Collection Kit, VRAYLAR, QULIPTA, HETLIOZ.
Industry payments across SC — which companies pay providers there.
